SCHEMBL24461291

SCHEMBL24461291

Cc1c(C2CNC2)[nH]c2nnc(-c3ccccc3O)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 4/20 0.39
▸ SMARCA2 P51531 12/20 0.39
▸ SMARCA4 P51532 12/20 0.39
▸ PBRM1 Q86U86 11/20 0.39
▸ MAPT P10636 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ NR1I2 O75469 9/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ CHUK O15111 1/20 0.36
▸ NR1H2 P55055 3/20 0.36
▸ NR1H3 Q13133 3/20 0.35
▸ CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31505612 1.00 IKBKB (0.39) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL30552632 0.88 SMARCA2 (0.42) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL30552600 0.88 SMARCA2 (0.42) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL24461569 0.88 SMARCA2 (0.42) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL24461651 0.86 PBRM1 (0.39) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL24461256 0.86 PBRM1 (0.39) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL30552520 0.86 PBRM1 (0.39) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL24461649 0.86 PBRM1 (0.39) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL30750942 0.86 PBRM1 (0.39) IKBKBSMARCA2SMARCA4PBRM1MAPT
SCHEMBL30552430 0.86 PBRM1 (0.39) IKBKBSMARCA2SMARCA4PBRM1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240024488-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2024-01-25 — — US disclosed
US-20240024488-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2024-01-25 — — US disclosed
WO-2022109426-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2022-05-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240024488-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB IKBKB 1896/4885SMARCA2 14/4885SMARCA4 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback